|
Market Closed -
NYSE
16:00:00 2026-10-16 EDT
|
5-day change | 1st Jan Change | ||
| 3.370 USD | +9.06% |
|
-7.16% | -46.34% |
| 09-14 | Armata Pharma Shares Rise on FDA Breakthrough Therapy Designation for Antibacterial Treatment | DJ |
| 09-14 | Armata Pharmaceuticals' AP-SA02 Gets FDA Breakthrough Therapy Designation | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 125M | - | - | - | ||
| 65B | |||||
| 51.2B | |||||
| 51.19B | |||||
| 43.93B | |||||
| 41.96B |
Select your edition
All financial news and data tailored to specific country editions
